Literature DB >> 1969136

Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression.

D Forrest1, A Muñoz, C Raynoschek, B Vennström, H Beug.   

Abstract

In contrast to the normal thyroid hormone receptor, the v-erbA product fails to bind hormone due to mutations in the C-terminal ligand binding domain and thus appears to represent a hormone-independent, oncogenic transcription factor. Therefore, we asked whether or not the C-terminal domain of v-erbA is required for its biological activity and putative transcriptional control functions by analysing mutants with altered C-termini. A v-erbA protein truncated in the C-terminal domain lacked detectable biological activity in transformed erythroblasts and its transcriptional repression function with respect to the band 3 gene was abolished. The protein displayed a nuclear location and could still bind to DNA, indicating that the N-terminal region retained DNA-binding activity but was insufficient to produce characteristic v-erbA changes in erythroblasts. Another biologically defective v-erbA variant with a small frameshift towards the extreme C-terminus also failed to repress band 3, indicating a requirement for a specific C-terminal structure in repression. However, this mutant retained partial biological activity, stimulating erythroblasts to grow at a higher rate than cells containing a completely inactive, deleted v-erbA gene. The results demonstrate that the mutated hormone-binding domain, in addition to the DNA-binding region, is critical for v-erbA biological and transcriptional control functions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969136

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Multiple mutations contribute to repression by the v-Erb A oncoprotein.

Authors:  Sangho Lee; Martin L Privalsky
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

2.  Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.

Authors:  K Damm; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

3.  Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses.

Authors:  A Baniahmad; S Y Tsai; B W O'Malley; M J Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

4.  Multiple thyroid hormone-induced muscle growth and death programs during metamorphosis in Xenopus laevis.

Authors:  Biswajit Das; Alexander M Schreiber; Haochu Huang; Donald D Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-04       Impact factor: 11.205

5.  A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor.

Authors:  A Baniahmad; A C Köhne; R Renkawitz
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

6.  Contrasting developmental and tissue-specific expression of alpha and beta thyroid hormone receptor genes.

Authors:  D Forrest; M Sjöberg; B Vennström
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

7.  Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype.

Authors:  S Fuerstenberg; I Leitner; C Schroeder; H Schwarz; B Vennström; H Beug
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

8.  Inserting the Ftz homeodomain into engrailed creates a dominant transcriptional repressor that specifically turns off Ftz target genes in vivo.

Authors:  A John; S T Smith; J B Jaynes
Journal:  Development       Date:  1995-06       Impact factor: 6.868

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.